CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors

Journal: Nature Immunology

Published: 2020-02-17

DOI: 10.1038/s41590-019-0589-5

Affiliations: 15

Authors: 20

Go to article
Institutions Share
Department of Oncology, UNIL, Switzerland 0.18
Ludwig Center for Cancer Research, UNIL, Switzerland 0.18
NYUAD Center for Genomics and Systems Biology, United Arab Emirates 0.10
Ludwig Collaborative Laboratory at MSK, United States of America (USA) 0.08
Parker Institute for Cancer Immunotherapy, United States of America (USA) 0.08
Department of Biomedicine Basel, Switzerland 0.08
EPFL Swiss Institute for Experimental Cancer Research (ISREC), Switzerland 0.05
Department of Medicine, MCW, United States of America (USA) 0.05
NYU Department of Medicine, United States of America (USA) 0.05
VIB-KU CCB Laboratory of Cellular Metabolism and Metabolic Regulation, Belgium 0.03
Laboratory of Cellular Metabolism and Metabolic Regulation (VRC), KU Leuven, Belgium 0.03
Leuven Cancer Institute (LKI), UZ Leuven, Belgium 0.03
Department of Medicine, MSKCC, United States of America (USA) 0.03
Department of Oncology, UB, Switzerland 0.03
Weill Cornell Medicine (WCM), Cornell University, United States of America (USA) 0.01

Return

Except where otherwise noted © 2020 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER